Physician profile
Jason Wulff
NPI 1760615777
$569.83
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $192 · 2023: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | $117.79 | 2022-2023 | Imbruvica, Epkinly |
| Novartis Pharmaceuticals Corporation | $112.15 | 2021-2023 | |
| Dova Pharmaceuticals | $50.72 | 2021 | |
| Amgen INC. | $50.06 | 2021-2023 | Lumakras |
| Astellas Pharma US INC | $47.84 | 2022-2023 | Padcev |
| Abbvie INC. | $38.48 | 2022-2023 | |
| Celgene Corporation | $33.78 | 2022-2023 | Reblozyl |
| Seagen INC. | $33.33 | 2022-2023 | Padcev |
| Bayer Healthcare Pharmaceuticals INC. | $20.98 | 2023 | |
| Karyopharm Therapeutics INC. | $18.86 | 2023 | Xpovio |
| Janssen Biotech, INC. | $16.18 | 2021 | |
| Genentech USA, INC. | $15.70 | 2022 | |
| Lilly USA, LLC | $13.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Wulff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.